Phase I study of weekly schedule of oxaliplatin, high-dose leucovorin and infusional fluorouracil in pretreated patients with advanced colorectal cancer.

被引：0
作者：
Rosati, G [1 ]
Rossi, A [1 ]
Bilancia, D [1 ]
Manzione, L [1 ]
机构：
[1] San Carlo Hosp, Med Oncol Unit, Potenza, Italy
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
H53
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [21] Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: A convenient treatment option in advanced gastric cancer
    Kundel, Yulia
    Purim, Ofer
    Figer, Arie
    Stemmer, Salomon M.
    Tichler, Thomas
    Sulkes, Jaqueline
    Sulkes, Aaron
    Brenner, Baruch
    MEDICAL SCIENCE MONITOR, 2008, 14 (04): : CR190 - CR195
  • [22] Oxaliplatin reintroduction in patients pretreated with leucovorin, fluorouracil and oxaliplatin for metastatic colorectal cancer (MCRC).
    Maindrault-Goebel, F
    Louvet, C
    André, T
    Carola, E
    Gilles, V
    Garcia, M
    Lotz, JP
    Izrael, V
    Krulik, M
    de Gramont, A
    ANNALS OF ONCOLOGY, 2000, 11 : 50 - 50
  • [23] Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma
    Hsiao, Sheng-Mou
    Chen, Chi-An
    Hsu, Chiun
    Lin, Ho-Hsiung
    Hsieh, Chang-Yao
    Wei, Lin-Hung
    ANTICANCER RESEARCH, 2008, 28 (3B) : 1887 - 1891
  • [24] A phase II study of irinotecan alternated with a weekly schedule of high-dose leucovorin and 48-hour 5-fluorouracil infusion in patients with metastatic colorectal cancer
    Rosati, G
    Rossi, A
    Reggiardo, G
    Manzione, L
    ONCOLOGY, 2002, 62 (03) : 209 - 215
  • [25] Biweekly bolus 5-fluorouracil and leucovorin plus oxaliplatin in pretreated patients with advanced colorectal cancer: a dose-finding study
    Yang, TS
    Chen, JS
    Tang, R
    Chiang, JM
    Hsieh, PS
    Yeh, CY
    Changchien, CR
    ANTI-CANCER DRUGS, 2003, 14 (02) : 145 - 151
  • [26] A dose escalating study of oxaliplatin and high dose weekly leucovorin and 5-fluorouracil in patients with advanced solid tumors
    Souglakos, J
    Kakolyris, S
    Vardakis, N
    Androulakis, N
    Mavroudis, D
    Vamvakas, L
    Kouroussis, C
    Agelaki, S
    Saridaki, Z
    Georgoulias, V
    CANCER INVESTIGATION, 2005, 23 (06) : 505 - 510
  • [27] Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: Results of a randomized multicenter trial
    Jager, E
    Heike, M
    Bernhard, H
    Klein, O
    Bernhard, G
    Lautz, D
    Michaelis, J
    zumBuschenfelde, KHM
    Knuth, A
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (08) : 2274 - 2279
  • [28] Activity and toxicity of oxaliplatin and bolus fluorouracil plus leucovorin in pretreated colorectal cancer patients: a phase II study
    Ferraresi, V
    Giampaolo, MA
    Gabriele, A
    Mansueto, G
    Buccilli, A
    Giannarelli, D
    Ciccarese, M
    Gamucci, T
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2005, 24 (02): : 187 - 195
  • [29] An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer
    Caponigro, F.
    Lacombe, D.
    Twelves, C.
    Bauer, J.
    Govaerts, A. -S.
    Marreaub, S.
    Milano, A.
    Anthoney, A.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (01) : 48 - 55
  • [30] Biweekly chemotherapy with oxaliplatin, irinotecan, infusional fluorouracil, and leucovorin: A pilot study in patients with metastatic colorectal cancer
    Falcone, A
    Masi, G
    Allegrini, G
    Danesi, R
    Pfanner, E
    Brunetti, IM
    Di Paolo, A
    Cupini, S
    Del Tacca, M
    Conte, P
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (19) : 4006 - 4014
12345